rs4622670

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_004304.5(ALK):​c.3359+6C>T variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.323 in 1,613,208 control chromosomes in the GnomAD database, including 91,119 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.25 ( 6046 hom., cov: 32)
Exomes 𝑓: 0.33 ( 85073 hom. )

Consequence

ALK
NM_004304.5 splice_region, intron

Scores

2
Splicing: ADA: 0.00005905
2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:9

Conservation

PhyloP100: -1.20

Publications

11 publications found
Variant links:
Genes affected
ALK (HGNC:427): (ALK receptor tyrosine kinase) This gene encodes a receptor tyrosine kinase, which belongs to the insulin receptor superfamily. This protein comprises an extracellular domain, an hydrophobic stretch corresponding to a single pass transmembrane region, and an intracellular kinase domain. It plays an important role in the development of the brain and exerts its effects on specific neurons in the nervous system. This gene has been found to be rearranged, mutated, or amplified in a series of tumours including anaplastic large cell lymphomas, neuroblastoma, and non-small cell lung cancer. The chromosomal rearrangements are the most common genetic alterations in this gene, which result in creation of multiple fusion genes in tumourigenesis, including ALK (chromosome 2)/EML4 (chromosome 2), ALK/RANBP2 (chromosome 2), ALK/ATIC (chromosome 2), ALK/TFG (chromosome 3), ALK/NPM1 (chromosome 5), ALK/SQSTM1 (chromosome 5), ALK/KIF5B (chromosome 10), ALK/CLTC (chromosome 17), ALK/TPM4 (chromosome 19), and ALK/MSN (chromosome X).[provided by RefSeq, Jan 2011]
ALK Gene-Disease associations (from GenCC):
  • neuroblastoma, susceptibility to, 3
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, ClinGen, Labcorp Genetics (formerly Invitae), Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.75).
BP6
Variant 2-29223336-G-A is Benign according to our data. Variant chr2-29223336-G-A is described in ClinVar as Benign. ClinVar VariationId is 259271.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.35 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_004304.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ALK
NM_004304.5
MANE Select
c.3359+6C>T
splice_region intron
N/ANP_004295.2
ALK
NM_001353765.2
c.155+6C>T
splice_region intron
N/ANP_001340694.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ALK
ENST00000389048.8
TSL:1 MANE Select
c.3359+6C>T
splice_region intron
N/AENSP00000373700.3
ALK
ENST00000638605.1
TSL:1
n.236+6C>T
splice_region intron
N/A
ALK
ENST00000618119.4
TSL:5
c.2228+6C>T
splice_region intron
N/AENSP00000482733.1

Frequencies

GnomAD3 genomes
AF:
0.246
AC:
37338
AN:
152028
Hom.:
6039
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0628
Gnomad AMI
AF:
0.180
Gnomad AMR
AF:
0.198
Gnomad ASJ
AF:
0.374
Gnomad EAS
AF:
0.0404
Gnomad SAS
AF:
0.349
Gnomad FIN
AF:
0.348
Gnomad MID
AF:
0.334
Gnomad NFE
AF:
0.354
Gnomad OTH
AF:
0.256
GnomAD2 exomes
AF:
0.285
AC:
71325
AN:
250108
AF XY:
0.301
show subpopulations
Gnomad AFR exome
AF:
0.0547
Gnomad AMR exome
AF:
0.162
Gnomad ASJ exome
AF:
0.380
Gnomad EAS exome
AF:
0.0376
Gnomad FIN exome
AF:
0.352
Gnomad NFE exome
AF:
0.354
Gnomad OTH exome
AF:
0.300
GnomAD4 exome
AF:
0.331
AC:
483731
AN:
1461062
Hom.:
85073
Cov.:
38
AF XY:
0.334
AC XY:
242802
AN XY:
726880
show subpopulations
African (AFR)
AF:
0.0529
AC:
1772
AN:
33474
American (AMR)
AF:
0.167
AC:
7460
AN:
44718
Ashkenazi Jewish (ASJ)
AF:
0.379
AC:
9893
AN:
26130
East Asian (EAS)
AF:
0.0328
AC:
1303
AN:
39696
South Asian (SAS)
AF:
0.362
AC:
31193
AN:
86240
European-Finnish (FIN)
AF:
0.349
AC:
18566
AN:
53182
Middle Eastern (MID)
AF:
0.358
AC:
2064
AN:
5768
European-Non Finnish (NFE)
AF:
0.353
AC:
392740
AN:
1111486
Other (OTH)
AF:
0.310
AC:
18740
AN:
60368
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.473
Heterozygous variant carriers
0
17625
35250
52874
70499
88124
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
12200
24400
36600
48800
61000
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.245
AC:
37334
AN:
152146
Hom.:
6046
Cov.:
32
AF XY:
0.242
AC XY:
18022
AN XY:
74366
show subpopulations
African (AFR)
AF:
0.0626
AC:
2600
AN:
41518
American (AMR)
AF:
0.198
AC:
3034
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.374
AC:
1298
AN:
3470
East Asian (EAS)
AF:
0.0401
AC:
208
AN:
5184
South Asian (SAS)
AF:
0.351
AC:
1690
AN:
4816
European-Finnish (FIN)
AF:
0.348
AC:
3678
AN:
10576
Middle Eastern (MID)
AF:
0.332
AC:
97
AN:
292
European-Non Finnish (NFE)
AF:
0.354
AC:
24037
AN:
67982
Other (OTH)
AF:
0.251
AC:
528
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1351
2702
4053
5404
6755
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
392
784
1176
1568
1960
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.309
Hom.:
12641
Bravo
AF:
0.221
Asia WGS
AF:
0.156
AC:
541
AN:
3478
EpiCase
AF:
0.343
EpiControl
AF:
0.343

ClinVar

ClinVar submissions as Germline

Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
5
Neuroblastoma, susceptibility to, 3 (5)
-
-
2
not provided (2)
-
-
2
not specified (2)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.75
CADD
Benign
0.18
DANN
Benign
0.78
PhyloP100
-1.2
PromoterAI
0.10
Neutral
Mutation Taster
=98/2
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.000059
dbscSNV1_RF
Benign
0.012
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs4622670; hg19: chr2-29446202; COSMIC: COSV66569119; API